Live price temporarily unavailable.
Price history
Edwards Lifesciences (EW) is a Health Care company in the S&P 500. Latest news and coverage below.
About Edwards Lifesciences
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
Recent News (13)
-
Edwards Lifesciences SVP sells $49,533 in stock
Edwards Lifesciences SVP sells $49,533 in stock
-
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
-
Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
-
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?
-
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match
-
Form 4 Edwards Lifesciences Corp For: 30 July Form 4 Edwards Lifesciences Corp For: 30 July
-
Form 4 Edwards Lifesciences Corp For: 27 July Form 4 Edwards Lifesciences Corp For: 27 July
-
Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares
-
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion? Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
-
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary
-
Edwards Lifesciences Q2 Earnings Call Highlights Edwards Lifesciences Q2 Earnings Call Highlights
-
Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth
-
More Health Care stocks
- ABT Abbott Laboratories
- BAX Baxter International
- BDX Becton Dickinson
- BSX Boston Scientific
- DXCM Dexcom
- GEHC GE HealthCare
- IDXX Idexx Laboratories
- ISRG Intuitive Surgical